Related Experiment Video
Updated: Aug 1, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Predicting therapeutic efficacy of oral rehydration salts in children with vasovagal syncope
Xiaojuan Du1, Chunyan Tao1, Xueying Li2
1Department of Pediatrics, Peking University First Hospital, Beijing, China.
Insights
A simple model using baseline hematocrit and body mass index (BMI) can predict the effectiveness of oral rehydration salts (ORS) in children with vasovagal syncope (VVS). This aids in tailoring treatment for better outcomes.
Area of Science:
- Pediatrics
- Cardiology
- Clinical Prediction Models
Background:
- Vasovagal syncope (VVS) is common in children, and oral rehydration salts (ORS) are used for treatment.
- Predicting the efficacy of ORS therapy in pediatric VVS patients is crucial for optimizing management.
- Current methods for predicting ORS efficacy in VVS are limited.
Purpose of the Study:
- To develop and validate an easy-to-perform and inexpensive predictive measure for ORS efficacy in children with VVS.
- To identify baseline clinical parameters associated with a positive response to ORS treatment.
- To create a predictive model for ORS treatment outcomes in pediatric VVS.
Main Methods:
- A cohort of 97 children diagnosed with VVS and treated with ORS was analyzed.
- Baseline demographic, hemodynamic, and red blood cell parameters were collected.
- Logistic regression was used to build a predictive model, validated with ROC curves and calibration tests.
Main Results:
- Higher baseline red blood cell count, hemoglobin, and hematocrit were observed in children who responded effectively to ORS.
- A predictive model incorporating baseline hematocrit and BMI demonstrated an area under the curve of 0.77 (p < 0.01).
- The model achieved 67.4% sensitivity and 80.9% specificity with optimal cut-off, showing good fitness and internal validation.
Conclusions:
- Baseline hematocrit and BMI are significant predictors of ORS therapeutic efficacy in children with VVS.
- The developed predictive model offers a reliable and accessible tool for assessing potential ORS treatment response.
- This model can assist clinicians in personalizing VVS management strategies for pediatric patients.
Objective:
This study was designed to develop an easy-to-perform and inexpensive measure to predict efficacy of the oral rehydration salts (ORS) in children with vasovagal syncope (VVS).
Materials And Methods:
Children diagnosed with VVS and treated with ORS for a median of 3 months at the Peking University First Hospital, China, were enrolled and followed up. Demographic data, clinical hemodynamic parameters, and variables related to red blood cells were collected at the baseline. On the basis of changes in symptom scores after treatment, participants were divided into effective or ineffective groups at the end of the follow-up. Logistic regression analysis was used to investigate parameters related to therapeutic efficacy of ORS and a predictive model of ORS effectiveness was created. The predictive efficiency was evaluated using the receiver operating characteristic curve. The accuracy/consistency was evaluated by the Hosmer-Lemeshow test and calibration curve. Internal validation was done using the bootstrap approach.
Results:
Totally 97 pediatric participants were included in the study and 4 (4.1%) were lost during the follow-up. ORS therapy was effective in 46 children and ineffective in 47 children. Children in the effective group had higher baseline red blood cell count, hemoglobin, and hematocrit than those in the ineffective group (p < 0.01). Through logistic regression analysis, the baseline hematocrit and body mass index (BMI) were included in predictive model for the response to ORS treatment. The predictive efficacy of the model showed an area under the curve of 0.77 (p < 0.01). The predicted probability cut-off value of 0.5 was found to be optimal, with a resulting sensitivity of 67.4% and specificity of 80.9%. In the Hosmer-Lemeshow test, p-value was 0.75, and the calibration plot showed a good model fitness. Internal validation was performed using the bootstrap approach (n = 1,000), showing 95% confidence interval of 0.67-0.86.
Conclusion:
Hemoglobin combined with BMI was useful for predicting the therapeutic efficacy of ORS in children with VVS.
Related Concept Videos
Pathophysiology of Vomiting
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Delivery: Enteral Route
Heart Failure Drugs: Inotropic Agents
Prevention of Further Absorption of Poison
Regulation of Water Intake

